CTSO vs NI · rev $18.5M vs P/E 23, rev $3.61B
Cytosorbents Crp (CTSO) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
CTSO currently screens at market cap $28.8M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the CTSO and NI stock pages for the full models.
Not investment advice.